Skip to main content
UniHealth

Doctor search

Peter S Galatin, MD

Hematology/Oncology · Stanford

NPI 1942311386

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Galatin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A85095 · Current

Licensed to practise in California · since 2003 · expires 2027-11-30 · Virginia Commonwealth University, Medical College of Virginia.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$223,233

Medicare paid this office $223,233 for 572 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)203$110,736$131
Return visit (30+ min)302$44,281$87
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's479$20,315$14
New patient visit (60+ min)120$18,517$154
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes42$10,784$106
See all 10 services
Every Original Medicare service billed
Long return visit (40+ min)203$110,736$131
Return visit (30+ min)302$44,281$87
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's479$20,315$14
New patient visit (60+ min)120$18,517$154
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes42$10,784$106
Initial hospital care with moderate level of medical decision making at least 75 minutes33$5,410$155
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or105$4,403$27
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$2,043$70
Telephone medical discussion with physician, 11-20 minutes19$1,845$84
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes23$723$31

Who their Medicare patients are

572 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 18% · Women 51% · Also on Medicaid 15% · Health risk score 2.01. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 75% · Coronary heart disease 34% · Diabetes 33% · Chronic kidney disease 31% · Cancer 27% · Atrial fibrillation 25% · Heart failure 24% · Depression 17% · COPD 13% · Stroke 11% · Dementia 9%.

The office billed $676,404, Medicare allowed $291,052 and paid $223,233; for 3,323 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20245723,323762.01$676,404$223,233
20235061,673761.84$414,416$165,737
20224711,565761.90$444,213$159,496
20214581,638762.00$481,011$163,258
20204201,457762.09$380,049$116,626
20194211,625761.85$299,413$135,680
20183921,295771.91$216,706$93,826
20174131,455772.01$251,091$93,549
20163901,363771.96$251,832$86,819
201536869,252771.90$3,001,030$753,969
2014358120,421771.80$4,627,552$1,052,178
201323721,916761.92$876,316$247,708

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Long return visit (40+ min)165$75,523$129
Return visit (30+ min)291$43,508$80
New patient visit (60+ min)106$16,579$156
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes58$11,464$103
Initial hospital care with moderate level of medical decision making at least 75 minutes44$6,987$146
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or90$4,777$29
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes22$1,827$68
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes12$399$31

2022: 9 services

Original Medicare services billed in 2022
Return visit (30+ min)306$59,865$85
Long return visit (40+ min)121$48,635$127
New patient visit (60+ min)82$13,502$165
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes51$11,500$93
Extended patient service without direct patient contact, first hour95$9,676$101
Initial hospital care with moderate level of medical decision making at least 75 minutes47$8,856$181
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$2,343$65
Biopsy and aspiration of bone marrow sample for diagnosis12$851$61
Telephone medical discussion with physician, 11-20 minutes14$803$54

2021: 9 services

Original Medicare services billed in 2021
Return visit (30+ min)309$58,838$83
Long return visit (40+ min)110$53,405$123
New patient visit (60+ min)81$14,128$174
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes48$11,060$93
Extended patient service without direct patient contact, first hour110$10,941$99
Initial hospital care with moderate level of medical decision making at least 75 minutes33$6,705$186
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes21$1,925$60
Telephone medical discussion with physician, 11-20 minutes18$1,039$58
Blood smear interpretation by physician with written report19$413$22

2020: 12 services

Original Medicare services billed in 2020
Return visit (30+ min)249$41,091$68
Long return visit (40+ min)91$20,515$101
New patient visit (60+ min)71$10,624$150
Extended patient service without direct patient contact, first hour93$10,457$104
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$10,367$97
Initial hospital care with moderate level of medical decision making at least 75 minutes47$9,185$187
Short return visit (20+ min)95$6,069$42
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$1,954$67
Telephone medical discussion with physician, 11-20 minutes21$1,124$49
Blood smear interpretation by physician with written report32$725$22
Blood smear interpretation by physician with written report20$469$23
Telephone medical discussion with physician, 5-10 minutes11$263$24

2019: 9 services

Original Medicare services billed in 2019
Return visit (30+ min)306$50,315$68
Long return visit (40+ min)111$28,779$99
Extended patient service without direct patient contact, first hour119$13,772$101
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes44$12,452$94
New patient visit (60+ min)74$10,701$145
Initial hospital care with moderate level of medical decision making at least 75 minutes39$9,361$184
Short return visit (20+ min)65$4,560$45
Extended patient service without direct patient contact, each additional 30 minutes12$592$49
Blood smear interpretation by physician with written report13$324$23

2018: 7 services

Original Medicare services billed in 2018
Return visit (30+ min)228$29,090$65
Long return visit (40+ min)77$13,603$94
Short return visit (20+ min)206$13,240$38
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$10,111$94
Extended patient service without direct patient contact, first hour83$9,018$99
New patient visit (60+ min)55$7,909$144
Initial hospital care with moderate level of medical decision making at least 75 minutes24$6,731$182

2017: 8 services

Original Medicare services billed in 2017
Short return visit (20+ min)289$27,945$41
Return visit (30+ min)192$25,962$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes34$9,161$93
Initial hospital care with moderate level of medical decision making at least 75 minutes33$7,977$181
New patient visit (60+ min)55$7,682$140
Long return visit (40+ min)49$7,300$96
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$4,081$65
New patient visit (45+ min)18$1,932$107

2016: 8 services

Original Medicare services billed in 2016
Short return visit (20+ min)251$26,295$40
Return visit (30+ min)173$23,485$65
New patient visit (60+ min)78$11,196$144
Long return visit (40+ min)48$6,278$95
Initial hospital care with moderate level of medical decision making at least 75 minutes28$5,829$177
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes22$4,446$91
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes33$4,411$63
New patient visit (45+ min)35$3,956$113

2015: 19 services

Original Medicare services billed in 2015
Injection, epoetin alfa, (for non-esrd use), 1000 units23$75,065None
Short return visit (20+ min)221$33,421$59
Short return visit (20+ min)205$17,883$45
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes62$12,465$64
Administration of chemotherapy into vein, 1 hour or less17$8,573$138
Injection of drug or substance under skin or into muscle41$8,209$25
Return visit (30+ min)58$7,470$90
Initial hospital care with moderate level of medical decision making at least 75 minutes31$6,528$176
Return visit (30+ min)49$5,033$69
New patient visit (60+ min)27$4,017$149
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less12$3,962$70
New patient visit (60+ min)23$3,893$169
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$3,616$90
Drawing of blood for a medical problem15$2,167$77
Long return visit (40+ min)14$1,857$133
New patient visit (45+ min)13$1,605$123
New patient visit (45+ min)14$1,604$115
Long return visit (40+ min)13$1,380$99
Injection of additional new drug or substance into vein13$926$23

2014: 23 services

Original Medicare services billed in 2014
Injection, epoetin alfa, (for non-esrd use), 1000 units36$119,518None
Short return visit (20+ min)261$53,158$67
Return visit (30+ min)97$17,367$98
Administration of chemotherapy into vein, 1 hour or less23$17,119$137
Injection of drug or substance under skin or into muscle56$12,226$25
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes42$10,312$64
New patient visit (60+ min)52$9,236$178
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes31$7,948$92
Injection, palonosetron hcl, 25 mcg11$7,178None
Drawing of blood for a medical problem22$5,551$103
Initial hospital care with moderate level of medical decision making at least 75 minutes28$5,443$176
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less20$5,047$70
Long return visit (40+ min)27$4,341$128
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less19$2,193$30
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour12$1,840$18
Injection of additional new drug or substance into vein14$1,769$22
Administration of chemotherapy into vein, each additional hour16$1,750$28
Injection of drug or substance into vein13$1,714$57
Short return visit22$1,038$42
Administration of influenza virus vaccine34$953$28
Infusion into a vein for hydration, each additional hour15$941$15
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)33$498$15
Injection, dexamethasone sodium phosphate, 1 mg11$87None

2013: 10 services

Original Medicare services billed in 2013
Injection, epoetin alfa, (for non-esrd use), 1000 units27$56,742None
Return visit (30+ min)115$21,911$93
Short return visit (20+ min)95$10,330$67
New patient visit (60+ min)45$8,077$179
Injection of drug or substance under skin or into muscle37$5,703$26
Long return visit (40+ min)21$3,593$133
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$3,542$62
Initial hospital care with moderate level of medical decision making at least 75 minutes17$3,514$176
Administration of influenza virus vaccine12$302$25
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)11$161$15

Medicaid work

$1,091 in 2023

Medicaid paid $1,091 for 73 billed services this clinician did in 2023, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
Long return visit (40+ min)59$742
Return visit (30+ min)14$349
Medicaid work by year
202373214$1,091
202138113$1,007
See the largest Medicaid services in earlier years

2021

Largest Medicaid services in 2021
Return visit (30+ min)38$1,007

Drugs they prescribed that Part D paid

$4,854,244

Pharmacies billed $4,854,244 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (11 of 921) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.

520 generic and fewer than 11 brand-name prescriptions · $4,854,244 in drug cost · 19 antibiotic prescriptions to 17 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lenalidomide30$554,786$18,493
Pomalyst24$553,559$23,065
Imbruvica24$393,166$16,382
Calquence29$341,321$11,770
Sprycel25$306,697$12,268
See all 25 drugs
Every Part D drug this clinician prescribed
Lenalidomide30$554,786$18,493
Pomalyst24$553,559$23,065
Imbruvica24$393,166$16,382
Calquence29$341,321$11,770
Sprycel25$306,697$12,268
Revlimid14$296,040$21,146
Doptelet15$250,227$16,682
Tagrisso13$213,260$16,405
Rubraca21$176,966$8,427
Gleevec12$88,901$7,408
Eliquis88$61,093$694
Deferasirox33$54,416$1,649
Xarelto30$24,670$822
Imatinib Mesylate11$3,047$277
Letrozole37$2,154$58
Hydroxyurea70$2,124$30
Dexamethasone44$759$17
Acyclovir26$711$27
Warfarin20$244$12
Allopurinol31$158$5
Ondansetron24$123$5
Prednisone18$90$5
Prochlorperazine Maleate11$87$8
Levothyroxine11$55$5
Lorazepam11$26$2

Year by year

Part D prescribing by year
20249211711% (11)None$4,854,244
20238301422% (16)None$3,540,936
2022627127NoneNone$3,460,915
20216391034% (25)43%$3,853,947
20205581043% (15)38%$2,187,240
20196681162% (14)30%$2,508,544
20188621364% (33)27%$1,815,183
20177831486% (45)29%$2,187,005
20167561356% (43)25%$1,721,131
20157281132% (12)34%$1,884,128
20145921187% (44)24%$678,868
20137291258% (60)17%$373,443

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Part D drugs prescribed in 2023
Imbruvica34$532,643$15,666
Jakafi18$300,890$16,716
Calquence19$286,784$15,094
Sprycel16$267,470$16,717
Doptelet14$248,381$17,742
Venclexta19$244,983$12,894
Lenalidomide16$219,857$13,741
Rubraca18$202,569$11,254
Eliquis63$41,971$666
Deferasirox43$26,985$628
Xarelto24$25,775$1,074
Abiraterone Acetate12$25,323$2,110
Hydroxyurea60$2,299$38
Dexamethasone46$984$21
Letrozole25$814$33
Acyclovir53$630$12
Warfarin17$196$12
Allopurinol21$169$8
Ondansetron14$168$12
Prednisone25$160$6
Montelukast11$35$3

2022: 15 drugs

Part D drugs prescribed in 2022
Revlimid52$1,068,389$20,546
Pomalyst21$441,203$21,010
Imbruvica27$421,767$15,621
Jakafi19$332,017$17,475
Brukinsa11$159,610$14,510
Eliquis56$32,923$588
Xarelto14$20,603$1,472
Zarxio12$16,363$1,364
Dexamethasone34$1,104$32
Hydroxyurea28$794$28
Ondansetron28$395$14
Prednisone21$282$13
Acyclovir15$179$12
Prochlorperazine Maleate11$108$10
Allopurinol18$107$6

2021: 16 drugs

Part D drugs prescribed in 2021
Revlimid110$2,077,936$18,890
Pomalyst41$816,119$19,905
Jakafi19$275,698$14,510
Imbruvica18$261,428$14,524
Deferasirox14$35,984$2,570
Eliquis31$16,476$531
Zarxio11$16,212$1,474
Hydroxyurea30$938$31
Levofloxacin14$565$40
Dexamethasone21$554$26
Hydrocodone-Acetaminophen19$398$21
Ondansetron27$361$13
Acyclovir12$343$29
Warfarin11$301$27
Prednisone26$227$9
Allopurinol17$110$6

2020: 16 drugs

Part D drugs prescribed in 2020
Revlimid59$900,718$15,266
Pomalyst28$534,738$19,098
Imbruvica20$271,345$13,567
Jakafi15$217,319$14,488
Xarelto18$12,261$681
Eliquis25$12,004$480
Hydroxyurea36$1,113$31
Warfarin21$764$36
Letrozole17$693$41
Prednisone31$614$20
Dexamethasone20$445$22
Acyclovir25$328$13
Ondansetron17$221$13
Hydrocodone-Acetaminophen11$121$11
Nystatin12$108$9
Lorazepam14$46$3

2019: 16 drugs

Part D drugs prescribed in 2019
Revlimid46$1,017,901$22,128
Pomalyst30$557,204$18,573
Jakafi36$297,725$8,270
Imbruvica16$208,476$13,030
Rubraca11$155,646$14,150
Imatinib Mesylate16$90,456$5,654
Hydroxyurea35$1,990$57
Gabapentin12$1,050$88
Levofloxacin16$1,003$63
Letrozole50$922$18
Dexamethasone32$644$20
Warfarin26$559$22
Acyclovir36$500$14
Prednisone31$245$8
Ondansetron16$162$10
Allopurinol14$155$11

2018: 23 drugs

Part D drugs prescribed in 2018
Revlimid39$740,449$18,986
Jakafi46$426,802$9,278
Imatinib Mesylate12$74,937$6,245
Xarelto25$12,375$495
Eliquis21$9,594$457
Exemestane11$5,334$485
Enoxaparin16$4,585$287
Hydroxyurea60$3,653$61
Duloxetine11$1,763$160
Letrozole74$945$13
Gabapentin14$881$63
Allopurinol42$876$21
Warfarin28$540$19
Dexamethasone26$486$19
Acyclovir35$479$14
Amoxicillin-Clavulanate Potass22$462$21
Anastrozole26$448$17
Ondansetron25$246$10
Hydrocodone-Acetaminophen13$227$17
Prednisone16$209$13
Omeprazole11$105$10
Levofloxacin12$87$7
Lorazepam17$69$4

2017: 21 drugs

Part D drugs prescribed in 2017
Revlimid53$1,023,894$19,319
Jakafi52$603,872$11,613
Imatinib Mesylate12$86,477$7,206
Xarelto24$10,647$444
Eliquis13$6,286$484
Enoxaparin13$5,978$460
Exemestane11$3,397$309
Hydroxyurea38$1,870$49
Allopurinol44$876$20
Warfarin29$665$23
Hydrocodone-Acetaminophen16$543$34
Morphine Sulfate Er11$534$49
Potassium Chloride16$504$32
Anastrozole35$499$14
Acyclovir29$496$17
Letrozole43$482$11
Ondansetron16$296$18
Prednisone25$274$11
Dexamethasone28$256$9
Lorazepam17$105$6
Prochlorperazine Maleate14$78$6

2016: 21 drugs

Part D drugs prescribed in 2016
Revlimid59$918,431$15,567
Jakafi28$263,241$9,401
Tasigna13$138,395$10,646
Gleevec11$100,485$9,135
Exemestane16$3,941$246
Enoxaparin12$3,705$309
Hydroxyurea73$2,082$29
Anagrelide16$1,346$84
Allopurinol60$888$15
Hydrocodone-Acetaminophen13$706$54
Dexamethasone36$543$15
Anastrozole48$542$11
Acyclovir27$370$14
Omeprazole21$343$16
Warfarin23$324$14
Phospha 250 Neutral15$303$20
Letrozole24$296$12
Prednisone24$274$11
Ondansetron17$228$13
Lorazepam13$79$6
Prochlorperazine Maleate11$67$6

2015: 18 drugs

Part D drugs prescribed in 2015
Jakafi61$700,357$11,481
Revlimid44$546,102$12,411
Imbruvica20$188,473$9,424
Gleevec16$159,831$9,989
Exjade16$87,215$5,451
Procrit15$31,560$2,104
Enoxaparin12$3,818$318
Anagrelide27$2,410$89
Hydroxyurea78$2,047$26
Allopurinol62$850$14
Anastrozole38$365$10
Ondansetron23$322$14
Dexamethasone35$307$9
Prednisone26$249$10
Warfarin14$245$17
Acyclovir24$243$10
Letrozole14$136$10
Prochlorperazine Maleate11$62$6

2014: 16 drugs

Part D drugs prescribed in 2014
Revlimid27$234,442$8,683
Jakafi21$166,435$7,925
Exjade13$47,652$3,666
Procrit17$29,133$1,714
Anagrelide23$2,880$125
Anastrozole54$1,516$28
Hydroxyurea49$1,191$24
Hydrocodone-Acetaminophen19$310$16
Tamoxifen Citrate15$299$20
Prednisone23$240$10
Allopurinol17$176$10
Dexamethasone20$157$8
Prochlorperazine Maleate18$145$8
Pantoprazole16$135$8
Lorazepam22$134$6
Levofloxacin12$122$10

2013: 16 drugs

Part D drugs prescribed in 2013
Enoxaparin12$7,791$649
Anastrozole124$4,264$34
Hydroxyurea83$2,749$33
Tamoxifen Citrate51$789$15
Letrozole13$613$47
Ondansetron Odt16$424$27
Hydrocodone-Acetaminophen16$363$23
Anagrelide12$314$26
Alendronate27$251$9
Methylphenidate14$249$18
Warfarin18$200$11
Prednisone28$136$5
Dexamethasone17$133$8
Allopurinol19$130$7
Prochlorperazine Maleate20$106$5
Lorazepam18$87$5

Money from drug and device companies

$509 in 2025

Industry payments by year
202522$492$509
202411None$129
202111None$14

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
StrykerNone$492
1 payment
  • Consulting · 2025-10-22 · $492
AstraZeneca Pharmaceuticals LPEnhertu$17
1 payment
  • Meals for Enhertu · 2025-10-17 · $17
See all 2 published payments
Every published payment
StrykerConsulting · 2025-10-22None$492
AstraZeneca Pharmaceuticals LPMeals · 2025-10-17Enhertu$17
See earlier years (2024, 2021)

2024: $129

Payments by company in 2024
AstraZeneca Pharmaceuticals LPLynparza$129
1 payment
  • Meals for Lynparza · 2024-12-18 · $129

2021: $14

Payments by company in 2021
Acrotech BiopharmaBeleodaq$14
1 payment
  • Education for Beleodaq · 2021-09-29 · $14

Professional record

NPI
1942311386
Licence
CA A85095California A85095: Current · expires 2027-11-30
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A850950
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X); Federal specialty code 207RH0000X (207RH0000X); Federal specialty code 207RH0003X (207RH0003X)
Mailing address
2589 Samaritan Dr, San Jose, CA, 95124
NPI first listed
2006-08-31
NPI last updated
2024-04-29
NPI record certified
2024-04-29

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 2585 Samaritan Dr, San Jose, CA, 95124